Jussi K. Huttunen

Jussi K. Huttunen's AcademicInfluence.com Rankings

Jussi K. Huttunen

Philosophy

#7299

World Rank

#10492

Historical Rank

Logic

#4356

World Rank

#5639

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jussi K. Huttunen's Degrees

Doctorate Medicine University of Helsinki
PhD Medicine University of Helsinki

Why Is Jussi K. Huttunen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jussi K. Huttunen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. (1987) (3747)
SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION (1988) (1697)
Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment (1992) (1360)
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. (1988) (1017)
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. (1998) (922)
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. (1996) (876)
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. (1992) (841)
ASSOCIATION BETWEEN CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION AND SERUM SELENIUM IN A MATCHED-PAIR LONGITUDINAL STUDY (1982) (578)
Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study (1992) (552)
Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. (1988) (525)
Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction (1997) (514)
A European evidence-based guideline for the prevention of type 2 diabetes. (2010) (453)
Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. (2003) (408)
Lycopene and myocardial infarction risk in the EURAMIC Study. (1997) (404)
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. (1991) (372)
Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. (1995) (365)
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. (1995) (357)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Dental infections in association with cerebral infarction in young and middle‐aged men (1989) (324)
Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. (1979) (324)
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. (1975) (321)
CONTROLLED, RANDOMISED TRIAL OF THE EFFECT OF DIETARY FAT ON BLOOD PRESSURE (1983) (320)
Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. (1998) (288)
Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study (1993) (287)
Association between serum selenium and the risk of cancer. (1984) (280)
Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients (1988) (258)
Fatty-acid composition of serum lipids predicts myocardial infarction. (1982) (251)
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). (1983) (250)
Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. (1983) (245)
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. (2010) (239)
Reproducibility and validity of dietary assessment instruments. II. A qualitative food frequency questionnaire. (1988) (233)
Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. (1976) (225)
Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study (1995) (224)
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. (1996) (219)
Postheparin Plasma Lipoprotein Lipase and Hepatic Lipase in Diabetes Mellitus: Relationship to Plasma Triglyceride Metabolism (1977) (218)
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. (1982) (200)
DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study (1997) (191)
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. (1997) (189)
Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. (1999) (174)
Serum selenium and the risk of coronary heart disease and stroke. (1985) (171)
Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. (1990) (170)
A Controlled Trial on the Effects of Patient Education in the Treatment of Insulin-dependent Diabetes (1983) (162)
Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. (1998) (162)
Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. (1985) (154)
Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate. (1991) (153)
Controlled Trial of α-Tocopherol and β-Carotene Supplements on Stroke Incidence and Mortality in Male Smokers (2000) (151)
Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. (1991) (142)
Serum ferritin and ceruloplasmin as coronary risk factors. (1994) (139)
The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. (1997) (125)
Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma. (1975) (123)
Effects of supplemental α-tocopherol and β-carotene on colorectal cancer: results from a controlled trial (Finland) (2000) (111)
Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. (1994) (109)
Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population. (1993) (106)
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. (2000) (105)
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. (2000) (105)
Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. (1997) (104)
Effect of α-tocopherol and β-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study (2004) (103)
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. (1979) (99)
The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up (1994) (98)
A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle. (1980) (98)
Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. (1998) (96)
The Helsinki Heart Study: central findings and clinical implications. (1991) (96)
Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. (1990) (95)
ATP-dependent and cyclic AMP-dependent activation of rat adipose tissue lipase by protein kinase from rabbit skeletal muscle. (1970) (93)
Effects of α‐tocopherol and β‐carotene supplementation on cancer incidence and mortality: 18‐Year postintervention follow‐up of the Alpha‐Tocopherol, Beta‐Carotene Cancer Prevention Study (2014) (92)
Prostate Cancer and Supplementation With -Tocopherol and -Carotene: Incidence and Mortality in a Controlled Trial (1998) (92)
Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia. (1977) (92)
Life-Style Factors and Risk for Abdominal Aortic Aneurysm in a Cohort of Finnish Male Smokers (2001) (92)
Activation and phosphorylation adipose tissue hormone-sensitive lipase by cyclic AMP-dependent protein kinase (1971) (90)
Concentration and composition of serum lipoproteins during a low-fat diet at two levels of polyunsaturated fat. (1985) (89)
Serum selenium and risk of cancer. A prospective follow‐up of nine years (1987) (88)
Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. (1983) (86)
Gastric Cancer and Premalignant Lesions in Atrophic Gastritis: A Controlled Trial on the Effect of Supplementation with Alpha-Tocopherol and Beta-Carotene (1998) (85)
Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland) (2000) (84)
Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. (1997) (83)
The effects of supplementation with α‐tocopherol and β‐carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial (1999) (83)
Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men. (1984) (83)
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) (2000) (78)
Protein kinase activation and phosphorylation of a purified hormone-sensitive lipase. (1970) (78)
Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change (1990) (77)
Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. (1989) (77)
Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention (1990) (77)
Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism. (1979) (76)
Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases. (2009) (74)
Qualitative and quantitative patterns of gangliosides in extraneural tissues. (1969) (73)
The α-tocopherol, β-carotene cancer prevention study (1997) (67)
Selenium and immune functions in humans (1983) (67)
Effect of guar gum on body weight and serum lipids in hypercholesterolemic females. (2009) (66)
Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium. (1993) (65)
Effect of Interferon on Plasma Lipoproteins and on the Activity of Postheparin Plasma Lipases (1982) (63)
The Effect of α-Tocopherol and β-Carotene Supplementation on Colorectal Adenomas in Middle-Aged Male Smokers (1999) (62)
The Helsinki Heart Study: basic design and randomization procedure. (1987) (61)
Effects of α‐tocopherol and β‐carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial (2007) (61)
Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland) (2002) (60)
Effects of α tocopherol and β carotene supplements on symptoms, progression, and prognosis of angina pectoris (1998) (58)
Heterogeneity of primary lipoprotein lipase deficiency. (1980) (58)
Effect of a diet low in saturated fatty acids on plasma lipids, lipoproteins, and HDL subfractions. (1984) (58)
Gemfibrozil: Effect on Serum Lipids, Lipoproteins, Postheparin Plasma Lipase Activities and Glucose Tolerance in Primary Hypertriglyceridæmia (1976) (57)
Health in Finland (2006) (57)
Partial purification and characterization of hormonesensitive lipase from rat adipose tissue (1970) (56)
von Willebrand factor antigen and dental infections. (1989) (55)
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. (2004) (48)
Effects of coffee and tea on lipoproteins and prostanoids. (1985) (48)
Properties of purified bovine milk lipoprotein lipase. (1976) (48)
Turku sugar studies XI. Effects of sucrose, fructose and xylitol diets on glucose, lipid and urate metabolism. (1976) (47)
The role of cyclic AMP in activation of hormone-sensitive lipase of adipose tissue. (1972) (47)
Selenium in food and nutrition in Finland. An overview on research and action. (1986) (46)
Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). (1996) (46)
The Helsinki Heart Study: coronary heart disease incidence during an extended follow‐up (1994) (45)
Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE. (2010) (45)
Selenium and cardiovascular diseases--an update. (1997) (45)
Fat composition of the infant diet does not influence subsequent serum lipid levels in man. (1983) (44)
Prospective study of diet, lifestyle, and intermittent claudication in male smokers. (2000) (44)
Nationwide Selenium Supplementation in Finland— Effects on Diet, Blood and Tissue Levels, and Health (1994) (43)
Leukocytes as a coronary risk factor in a dyslipidemic male population. (1992) (43)
Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels. (1990) (42)
The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. (1999) (42)
LOWERED HDL CHOLESTEROL AND INCIDENCE OF ISCHAEMIC HEART DISEASE (1981) (41)
Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. (1998) (40)
Beta-carotene did not work: aftermath of the ATBC study. (1997) (40)
Seasonal variation in high density lipoprotein cholesterol. (1993) (39)
Molecular Genetic Study of Finns With Hypoalphalipoproteinemia and Hyperalphalipoproteinemia A Novel Gly230Arg Mutation (LCATFin) of Lecithin:Cholesterol Acyltransferase (LCAT) Accounts for 5% of Cases With Very Low Serum HDL Cholesterol Levels (1998) (38)
Lipoproteins and coronary heart disease in the Helsinki Heart Study. (1990) (36)
Improving the world's health through national public health institutes. (2005) (36)
Purification and characterization of lipoprotein lipase from pig myocardium. (1975) (34)
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. (1999) (34)
Selenium and cardiovascular disease. (2009) (34)
Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II. (1980) (33)
Long-term use of probucol in the multifactorial primary prevention of vascular disease. (1986) (32)
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial. (1999) (31)
Dietary determinants of plasma high-density lipoprotein cholesterol. (1987) (31)
α-Tocopherol (vitamin E) and β-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial (2001) (30)
Effect of Fasting on Two Postheparin Plasma Triglyceride Lipases and Triglyceride Removal in Obese Subjects (1975) (30)
A purified triglyceride lipase, lipoprotein in nature, from rat adipose tissue. (1970) (30)
The HPLC determination of total thiamin (Vitamin B1) in foods (1993) (30)
A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes. (2009) (30)
Dietary intake and gene variation influence the response of plasma lipids to dietary intervention (1992) (29)
EURAMIC Study: antioxidants, myocardial infarction and breast cancer. Design and main hypotheses. (1993) (29)
Dietary therapy in diabetes mellitus. Description of a recommendation prepared by the Finnish Diabetes Association's Committee on Nutrition Therapy. (2009) (29)
Association Between β-Carotene and Acute Myocardial Infarction Depends on Polyunsaturated Fatty Acid Status The EURAMIC Study (1995) (28)
Lack of serum cholesterol-lowering effect of skimmed milk and butter milk under controlled conditions. (1981) (27)
Postintervention Effect of Alpha Tocopherol and Beta Carotene on Different Strokes: A 6-Year Follow-Up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study (2004) (26)
Effect of acute ethanol load on postheparin plasma lipoprotein lipase and hepatic lipase activities and intravenous fat tolerance. (1978) (25)
Angiotensin‐converting enzyme genotypes in the high‐ and low‐risk area for coronary heart disease in Finland (1995) (25)
Effect of alpha-tocopherol (vitamin E) and beta-carotene supplementation on the incidence of intermittent claudication in male smokers. (1997) (25)
HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial. (1982) (24)
Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. (2001) (23)
Effect of probucol on the activity of postheparin plasma lipoprotein lipase and hepatic lipase. (1981) (23)
Quantitative determination of urinary neuraminyl oligosaccharides by gas-liquid chromatography. (1969) (23)
Alcohol intake and risk of breast cancer: the euramic study. (1997) (22)
EFFECT OF ACTIVATED CHARCOAL ON HYPERCHOLESTEROLAEMIA (1986) (21)
Serum selenium in acute infections (1988) (21)
Fructose in medicine (1971) (21)
Postheparin plasma lipoprotein lipase and hepatic lipase in normal human subjects: relationship to age, sex and triglyceride metabolism. (1977) (21)
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels. (1998) (20)
Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism. (1981) (19)
Activation and phosphorylation of purified adipose tissue hormone-sensitive lipase by cyclic AMP-dependent protein kinase. (1971) (19)
Increased urinary excretion of neuraminic acid-containing oligosaccharides after myocardial infarction. (1972) (18)
Remissions in newly diagnosed Type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy (1984) (17)
Vitamin E does not influence plasma lipoprotein metabolism in healthy subjects with normal nutritional status. (1982) (17)
Clinical experience with probucol with special emphasis on mode of action and long-term treatment. (1982) (16)
Postheparin Plasma Lipase in Human Subjects.: Studies with Chylomicrons, Very‐Low Density Lipoproleins and a Fat Emulsion (1973) (16)
Two new immunogenetic polymorphisms of the apoB gene and their effect on serum lipid levels and responses to changes in dietary fat intake. (1995) (15)
DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment (1991) (15)
Heterogeneity of salt‐resistant lipase from human postheparin plasma (1975) (15)
Dietary fat and blood pressure--a review. (1987) (14)
Selenium in cardiovascular diseases. (1986) (14)
GLUCURONIDATION IN RATS OF DIFFERENT AGES AND STRAINS. (1965) (13)
The HPLC determination of total riboflavin in foods (1990) (13)
Low postheparin plasma hepatic lipase activity in familial type IIa hyperlipoproteinemia. (1976) (13)
Minerals, trace elements and cardiovascular disease. An overview. (1988) (12)
Glucuronidation of 5-hydroxyindole derivatives in vitro. (1965) (12)
Apolipoprotein E polymorphism and dietary plasma cholesterol response. (1995) (12)
Predictive value for coronary heart disease of baseline high-density and low-density lipoprotein cholesterol among Fredrickson type IIa subjects in the Helsinki Heart Study. (1990) (12)
Physical activity and plasma lipids and lipoproteins. (1982) (10)
3.P.40 Alpha-tocopherol and beta-carotene supplementation in primary prevention of major coronary events (1997) (10)
Cholestanol and fatty acids of serum lipids as risk factors of stroke. (1986) (10)
EFFECT OF DISCONTINUATION OF BIGUANIDE THERAPY ON METABOLIC CONTROL IN MATURITY-ONSET DIABETICS (1980) (10)
Effect of bacterial lipopolysaccharide on serum lipids and on the development of aortic atherosclerosis in rabbits. (1986) (8)
Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levels (1989) (8)
Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men. (1979) (7)
HDL-Cholesterol as a Risk Factor in Coronary Heart Disease (2012) (7)
Serum HDL cholesterol in a high coronary risk population in eastern Finland. (2009) (7)
Serum lipids, uric acid and glucose during chronic consumption of fructose and xylitol in healthy human subjects. (1976) (6)
High‐density lipoprotein cholesterol elevation with gemfibrozil: Effects of baseline level and modifying factors (1993) (6)
Selenium in human disease. (1985) (6)
Lifestyle determinants of HDL2- and HDL3-cholesterol levels in a hypercholesterolemic male population. (1991) (6)
Intrapartum stress Sowers the concentration of high density lipoprotein cholesterol in cord plasma (1981) (5)
Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study 1–4 (1999) (5)
CHLAMYDIA TWAR AND ACUTE MYOCARDIAL INFARCTION (1989) (5)
Effect of furosemide on the lipid abnormalities in chronic renal failure. (2009) (5)
Reduction in Q wave myocardial infarctions with gemfibrozil in the Helsinki Heart Study. (1990) (5)
Dietary lipids and coronary heart disease. Epidemiological evidence. (1992) (5)
Why did antioxidants not protect against lung cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study? (1996) (4)
Supplementation of a Population with Selenium — Reasons for Action and Initial Experience (1989) (4)
Evaluation of Patient Education: A Reply (1983) (4)
Molecular genetic study of Finns with hypo- and hyperalphalipoproteinemia: a novel Gly230Arg mutation (LCATFin) of the lecithin-cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels (1998) (4)
Apolipoprotein E 4 Homozygosity Predisposes to Serum Cholesterol Elevation during High Fat Diet (2005) (4)
Dietary factors and hypertension. (2009) (4)
Helsinki Heart Study. New perspectives in the prevention of coronary heart disease. (1988) (4)
Fractionation of Urinary Low Molecular Weight Carbohydrate-Containing Compounds. (1964) (3)
National Public Health Institutes: European perspective (2011) (3)
Role of dietary fats in blood pressure control (1983) (3)
NEW RISK-FACTORS FOR STROKE (1988) (3)
Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid (1984) (3)
Beta-carotene, vitamin A and prostatic cancer. (1992) (2)
Lipoprotein lipase and hepatic lipase activity in post-heparin plasma of patients with hypertriglyceridemia. (1977) (2)
Impaired chronotropic response to beta-stimulation in chronic coronary artery disease. (1973) (2)
Micronutrients and other microconstituents (1986) (2)
The mechanism of activation of hormone-sensitive lipase. (1971) (2)
[Serum selenium and risk of death in coronary disease]. (1983) (1)
1.P.164 Alpha-tocopherol and beta-carotene supplementation and incidence of intermittent claudication (1997) (1)
Evaluation of human trial findings. (1996) (1)
[Prevention of blood pressure diseases and non-drug management]. (1989) (1)
Predictive value of current cigarette smoking, pack years and tar exposure in the estimation of lung cancer risk (1991) (1)
Isolation of neuraminlactose from human male urine. (1965) (1)
The knowledge and attitudes of the Finnish public and physicians on cholesterol and coronary heart disease (1992) (1)
The Effect of Alpha-Tocopherol and Beta-Carotene Supplementation on CORD Symptons (1997) (1)
Lipid Level Alterations in the Helsinki Heart Study-Reply (1989) (0)
Antioxidants and ischaemic heart disease (1997) (0)
SELENIUM SUPPLEMENTATION IN HUMANS (1988) (0)
Antioxidants and ischaemic heart disease (Letter) (1997) (0)
New mutations in the apolipoprotein B gene (1994) (0)
Clinical Significance of Vitamins A, C and E (1988) (0)
[Management of blood pressure in the elderly]. (1989) (0)
Epidemiological studies on coronary death and cancer. (1990) (0)
Does alpha-tocopherol and beta-carotene supplementation prevent abdominal aortic aneurysm? (2000) (0)
Lack of Correlation Between Serum Dopamine‐/3‐Hydroxylase Activity and Blood Pressure in Middle‐aged Men (1979) (0)
Measurement of Post-Heparin Plasma Lipoprotein Lipase and Hepatic Triglyceride Lipase Activities and Their Relation to Plasma Triglyceride Metabolism (1977) (0)
[Finnish coronary heart disease]. (1991) (0)
The alpha-tocopherol, beta carotene cancer prevention study, a controlled trial with antioxidant vitamins: results for cancer and ischemic heart disease (1994) (0)
Mental health in Nepal: A community survey of Anandaban Village in Western region of Nepal (2000) (0)
[Is dietary salt restriction highly dangerous?]. (1998) (0)
[Comparative study on the effects of carbimazole and propranolol in 131I-therapy of hypothyroidism]. (1980) (0)
Effect of alpha-tocopherol (vitamin E) and beta-carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease (1998) (0)
Epidemiology and prevention of coronary heart disease in North Karelia: results from the North Karelia project and associated studies with special reference to nutrition and serum cholesterol (1982) (0)
1.P.256 LCAT deficiency caused by a novel LCATFin (Gly230Arg) and LCAT Arg399Cys mutations; Increased frequency of LCATFin among subjects with low HDL-C levels (1997) (0)
Effect of Fasting on Two Postheparin Plasma Triglyceride Lipases and Triglyceride Removal in Obese Subjects (1975) (0)
STUDIES Dietary instructions 2 months LABORATORY STUDIES II Random izat ion GROUP A GROUP B Mild exercise 2 months LABORATORY STUDIES Moderate exercise 2 months LABORATORY STUDIES (2005) (0)
DDT (dicophane) and postmenopausal breast cancer in (2016) (0)
World Health Organization MONICA Project. A worldwide monitoring system for cardiovascular diseases: cardiovascular mortality and risk factors in selected communities. In:World Health Statistics Annual 1987, pp27-59, Geneva: WHO (2014) (0)
The World Health Organisation (1949) (0)
ANTIOXIDANTS AND ISCHAEMIC HEART DISEASE. AUTHORS' REPLY (1997) (0)
Fructose inmedicine A review withparticular reference todiabetes mellitus (1971) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jussi K. Huttunen?

Jussi K. Huttunen is affiliated with the following schools:

University of Helsinki